×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2: An Overview of Biosimilars and Interchangeable Biosimilars in the U.S.
Speaker(s)
Dr. Stacey Ricci
US FDA, United States
Director, Scientific Review Staff, OTBB, CDER
Have an account?